VEGFA and neoplasm: Additionally, recombinant oncolytic vaccinia virus GLV-5b451 expressing anti-VEGF single-chain antibody (GLAF-2) demonstrated significant inhibition of feline mammary carcinoma growth in xenograft mouse models, reducing tumor angiogenesis and VEGF expression within tumors (Adelfinger et al., 2014)​.